Beryllium sensitivity monitoring shall consist of medical examinations to confirm and monitor the extent and nature of a covered Part B employee's beryllium sensitivity. Monitoring shall also include regular medical examinations, with diagnostic testing, to determine if the covered Part B employee has established chronic beryllium disease.
source: 71 FR 78534, Dec. 29, 2006, unless otherwise noted.
cite as: 20 CFR 30.508